ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

STELARA
Arthritis/rheumatic disorders
Psoriasis
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

STELARA Rx

Generic Name and Formulations:
Ustekinumab 45mg/0.5mL, 90mg/1mL; soln for SC inj; preservative-free.

Company:
Janssen Biotech, Inc.



Therapeutic Use:

Indications for STELARA:

Treatment of adults with active psoriatic arthritis; may be used alone or in combination with methotrexate.

Adult Dose for STELARA:

≥18yrs: 45mg SC once then 4 weeks later, followed by 45mg every 12 weeks. Co-existent moderate-to-severe plaque psoriasis weighing >100kg: 90mg once then 4 weeks later, followed by 90mg every 12 weeks. Rotate inj site.

Children's Dose for STELARA:

<18yrs: not evaluated.

Pharmacological Class:

Interleukin-12 and interleukin-23 antagonist.

Rems:

YES

Warnings/Precautions:

Active infections: do not initiate therapy. Chronic or history of recurrent infection. Conditions that predispose to infection. Increased risk of serious or fatal infections, esp. in IL-12/IL-23 genetically deficient patients (eg, mycobacteria, salmonella, BCG vaccines). Monitor for new infection; discontinue if serious infection develops. Test for and treat latent tuberculosis prior to initiating therapy. Avoid close contact with live vaccine recipients. History of malignancies. Monitor for appearance of non-melanoma skin cancer. Discontinue if reversible posterior leukoencephalopathy syndrome (RPLS) occurs or is suspected. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Concomitant live vaccines, other immunosuppressants, phototherapy: not recommended. Do not give BCG vaccines during or within 1 year of starting or stopping ustekinumab. Non-live vaccines: may get suboptimal response. May affect CYP450 substrates. Caution with concomitant allergen immunotherapy (esp. for anaphylaxis).

Adverse Reactions:

Nasopharyngitis, upper respiratory tract infection, headache, fatigue; infections, malignancies, RPLS, hypersensitivity reactions (discontinue if occurs).

Generic Availability:

NO

How Supplied:

Single use vial—1; single use prefilled syringe—1

STELARA

  • 0.5ml of 45mg/0.5ml syringes (Qty:1)
  • appx. price $7799.00
GoodRx

Indications for STELARA:

Moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy.

Adult Dose for STELARA:

≥18yrs: ≤100kg: 45mg SC once then 4weeks later, then once every 12weeks. >100kg: 90mg once then 4weeks later, then once every 12weeks. Rotate inj site.

Children's Dose for STELARA:

<18yrs: not evaluated.

Pharmacological Class:

Interleukin-12 and interleukin-23 antagonist.

Rems:

YES

Warnings/Precautions:

Active infections: do not initiate therapy. Chronic or history of recurrent infection. Conditions that predispose to infection. Increased risk of serious or fatal infections, esp. in IL-12/IL-23 genetically deficient patients (eg, mycobacteria, salmonella, BCG vaccines). Monitor for new infection; discontinue if serious infection develops. Test for and treat latent tuberculosis prior to initiating therapy. Avoid close contact with live vaccine recipients. History of malignancies. Monitor for appearance of non-melanoma skin cancer. Discontinue if reversible posterior leukoencephalopathy syndrome (RPLS) occurs or is suspected. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Concomitant live vaccines, other immunosuppressants, phototherapy: not recommended. Do not give BCG vaccines during or within 1 year of starting or stopping ustekinumab. Non-live vaccines: may get suboptimal response. May affect CYP450 substrates. Caution with concomitant allergen immunotherapy (esp. for anaphylaxis).

Adverse Reactions:

Nasopharyngitis, upper respiratory tract infection, headache, fatigue; infections, malignancies, RPLS, hypersensitivity reactions (discontinue if occurs).

Generic Availability:

NO

How Supplied:

Single use vial—1; single use prefilled syringe—1

STELARA

  • 0.5ml of 45mg/0.5ml syringes (Qty:1)
  • appx. price $7799.00
GoodRx

Sign Up for Free e-newsletters